Fingerprint
Dive into the research topics where Kelly K Hunt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Axillary Management after Neoadjuvant Endocrine Therapy (NET)
Leonard, L., Yi, M., Wingate, E., Singh, P., Caudle, A., Hwang, R. F., Bedrosian, I., Valero, V., Litton, J., Ibrahim, N. & Hunt, K. K., Apr 2026, In: Annals of surgical oncology. 33, 4, p. 3327-3337 11 p.Research output: Contribution to journal › Article › peer-review
-
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction
Luo, L., Wang, Y., Bui, T., Jiang, X., Chen, M. K., Rao, X., Mohammadhosseinpour, S., Li, M., Kim, S., Kim, R. Y., Kamaliasl, S., Ulizio, C. W., Tsavachidis, S., Navarro-Yepes, J., Kettner, N. M., Wingate, H., Meric-Bernstam, F., Hunt, K. K., Wang, J. & Faia, K. & 1 others, , Dec 2026, In: Nature communications. 17, 1, 619.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Development of a Reproducible Framework and Pathway to Support Innovation in an Academic Surgical Department
Alpard, S. K., Hunt, K. K., Tran, J. & Checka, C. M., Mar 2026, In: Annals of surgical oncology. 33, 3, p. 2363-2371 9 p.Research output: Contribution to journal › Article › peer-review
-
Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2− Breast Cancer Undergoing Mastectomy
Chen, J. H., Wanis, K. N., Rahman, M., Gianchandani, A., Bedrosian, I., Tamirisa, N., Yi, M., Raghavendra, A., Singh, P., Teshome, M., Sun, S., Kuerer, H., Hunt, K. K., Meric-Bernstam, F. & Adesoye, T., 2026, (Accepted/In press) In: Annals of surgical oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer
Singareeka Raghavendra, A., Liu, D. D., Damodaran, S., Pasyar, S., Shen, Y., Mouabbi, J. A., Barcenas, C. H., Hunt, K. K. & Tripathy, D., Jan 2026, In: Cancers. 18, 2, 253.Research output: Contribution to journal › Article › peer-review
Open Access